Good to see they are advancing drill operations for the Lithium and base metal projects in Australia but I just feel this should have been done earlier. It's great having so many potential projects but at what point does it become too many fingers in too many pies.
The market has not reacted with anything to do with Kambale. Aussie investors want to see the advancement of Aussie based projects. The only exception is if a project is too stellar to look past. Kambale isn't in that category imo. There are better graphite jnr projects in Australia than Kambale. We also have our own graphite tenements in WA. I would prefer to see them look to sell Kambale in the hopes the money could be used to speed up the projects back home, but until the drills hit the ground and show what is under the surface then Kambale advancement acts as a plan B 'should' the results not be as we hope back home.
Management have made it clear that they see themselves as an 'incubator' company. This means with all likelihood that getting Kambale to a point where the project could be sold is probably what they are looking towards. Hoping to perhaps get the drill results for either (or both, fingers crossed) Lithium/base metal projects and then potentially selling Kambale in order to speed up the process back home.
It has been a real slug for CDT holders and we have been very patient. I do like that they are advancing the projects at home but their wording about drilling doesn't inspire hope that the drills will be in the ground this quarter, let alone seeing results. Will be H2 of 2023 by the looks of things. It isn't necessary the end of the world but at some point holders (myself included) could look to cut losses before end of financial year and start fresh in the new one once the drills hit the Aussie land.
- Forums
- ASX - By Stock
- CDT
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-4
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CDT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
-0.001(20.0%) |
Mkt cap ! $3.334M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $5.52K | 2.75M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 23503938 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 16377327 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 23503938 | 0.002 |
19 | 31891987 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 16377327 | 11 |
0.004 | 15529857 | 14 |
0.005 | 8380466 | 10 |
0.006 | 1084507 | 5 |
0.007 | 360384 | 3 |
Last trade - 15.36pm 13/11/2024 (20 minute delay) ? |
Featured News
CDT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online